Through pharmaceutical research and development efforts, Janssen is creating innovative solutions and medications that can help patients live a better life with diabetes.
Building upon a long-standing commitment to immunology, the Company continues to deliver new options to combat complex conditions, including rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, inflammatory bowel diseases and psoriasis.
The company’s vision is to make a meaningful difference in the lives of patients suffering from dermatological disorders. The focus is on skin, hair and nail diseases, with an innovative product range adding value for better management of dermatological diseases.
With the goal of improving public health by fighting infectious diseases, the company is committed to delivering treatment for people living with multi drug resistant tuberculosis.
With a continued, deep-rooted commitment to neuroscience, the company’s vision is to reduce the burden, disability and devastation caused by serious neuropsychiatric diseases and pain conditions, and restore hope for patients. The areas of focus include: Neurology, which includes Alzheimer’s disease; Psychiatry, such as schizophrenia and mood disorders such as bipolar disease and major depressive disorder; and Schizophrenia and Pain, with special focus on chronic pain states and neuropathic pain.
Through groundbreaking research and innovative partnerships, Janssen aims to transform cancer into a preventable or curable disease. The Company’s goal is to deliver therapeutic options that prolong and improve patients’ lives. Janssen is focused on key cancer types, including hematologic malignancies, prostate cancer, ovarian cancer and soft tissue sarcomas. It is dedicated to helping realize the promise of winning the “war on cancer”.